Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

381.32
Delayed Data
As of 4:00pm ET
 +0.54 / +0.14%
Today’s Change
340.09
Today|||52-Week Range
543.55
+3.88%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$40.9B

Company Description

Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in inventing medicines for people with serious diseases. It includes Arcalyst, Dupixent, Eylea, Kevzara, and Praluent injections. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Contact Information

Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown New York 10591-6707
P:(914) 847-7000
Investor Relations:

Employees

Shareholders

Mutual fund holders42.63%
Other institutional27.43%
Individual stakeholders25.33%

Top Executives

Leonard S. SchleiferPresident, Chief Executive Officer & Director
Robert E. LandryChief Financial Officer & Senior VP-Finance
George Damis YancopoulosDirector & Chief Scientific Officer
Beth F. LevineSenior Vice President & Chief Compliance Officer
Daniel P. Van PlewSVP, GM-Industrial Operations & Product Supply